DAVID PARKINSON

M.D., President & CEO, Nodality

Dr. Parkinson is President and CEO of Nodality, a South San Francisco-based biotechnology company. Until October 2007 Dr. Parkinson was Sr. Vice President, Oncology Research and Development at Biogen Idec, where he oversaw all oncology discovery research efforts and the development of the oncology pipeline. Previously he had served as Vice President, Oncology Development at Amgen and Vice President, Global Clinical Oncology Development at Novartis. He is a past Chairman of the FDA Biologics Advisory Committee and is a recipient of the FDA's Cody Medal. He has recently completed terms as a member of the FDA's Science Board and as an elected Director on the Board of Directors of the American Association of Cancer Research.

 
Web Analytics